Showing results (31-40 of 124) with videos related to
Sort By:
Pageof 13
Clinical Kidney Journal|July 4, 2025
Chronic kidney disease is associated with incident depression requiring treatment: a retrospective cohort studyAndreas Kommer, Paul Christoph Claßen, Eva Maria Schleicher, et al.Pharmacology & Therapeutics|July 26, 2023
A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathyAqsa Ashfaq, Myriam Meineck, Andrea Pautz, et al.Metabolites|November 26, 2025
Disease and Medication Context Shape Ex Vivo Metabolite Stability: A Pilot Study in Systemic Lupus ErythematosusFabian Schmitt, Susanne Nguyen, Paul Christoph Claßen, et al.The Biochemical Journal|December 23, 2018
The KH-type splicing regulatory protein (KSRP) regulates type III interferon expression post-transcriptionallyLisa Schmidtke, Katharina Schrick, Sabrina Saurin, et al.Frontiers in Pharmacology|June 29, 2023
The macrocyclic lactone oxacyclododecindione reduces fibrosis progressionSabrina Saurin, Myriam Meineck, Markus Rohr, et al.Pathogens (Basel, Switzerland)|April 30, 2021
COVID-19-Importance for Patients on the Waiting List and after Kidney Transplantation-A Single Center Evaluation in 2020-2021Simone C Boedecker, Pascal Klimpke, Daniel Kraus, et al.Infection|April 11, 2025
Burden of COVID-19 in immunocompromised patients in Germany: a retrospective, observational Study on Health Insurance Data from 2021 to 2022Julia Weinmann-Menke, Clemens-Martin Wendtner, Dennis Häckl, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 13, 2026
Bleeding risk after kidney biopsy with platelet inhibitionDaniel Kraus, Razan Sadek, Andreas Kommer, et al.Rheumatology (Oxford, England)|May 1, 2020
Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritisIoannis Parodis, Christina Adamichou, Selda Aydin, et al.Clinical Case Reports|November 13, 2023
Plasma exchange for treatment of a therapy-related thrombotic microangiopathy in a patient with advanced hepatocellular carcinoma-A case reportMarco Stortz, Kateryna Shmanko, Daniel Kraus, et al.Pageof 13